Legis Daily

Independent Drug Value Assessment Act of 2024

USA118th CongressHR-6977| House 
| Updated: 1/12/2024
Jerrold Nadler

Jerrold Nadler

Democratic Representative

New York

Cosponsors (2)
Shri Thanedar (Democratic)Katie Porter (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
View Full Text
Timeline

Bill from Previous Congress

HR 117-9321
Independent Drug Value Assessment Act
Jan 11, 2024
Introduced in House
Jan 11, 2024
Referred to the House Committee on Energy and Commerce.
Jan 12, 2024
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 117-9321
    Independent Drug Value Assessment Act


  • January 11, 2024
    Introduced in House


  • January 11, 2024
    Referred to the House Committee on Energy and Commerce.


  • January 12, 2024
    Referred to the Subcommittee on Health.

Health

Independent Drug Value Assessment Act of 2024

USA118th CongressHR-6977| House 
| Updated: 1/12/2024
View Full Text
Timeline

Bill from Previous Congress

HR 117-9321
Independent Drug Value Assessment Act
Jan 11, 2024
Introduced in House
Jan 11, 2024
Referred to the House Committee on Energy and Commerce.
Jan 12, 2024
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 117-9321
    Independent Drug Value Assessment Act


  • January 11, 2024
    Introduced in House


  • January 11, 2024
    Referred to the House Committee on Energy and Commerce.


  • January 12, 2024
    Referred to the Subcommittee on Health.
Jerrold Nadler

Jerrold Nadler

Democratic Representative

New York

Cosponsors (2)
Shri Thanedar (Democratic)Katie Porter (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted